Diabetic Foot Infections: Characteristics and Management

Microbiology of Diabetic Foot Infections

Diabetic foot infections are commonly polymicrobial, with cultures typically yielding 3-5 different bacterial isolates 2
Acute infections in antibiotic-naïve patients are often monomicrobial (usually aerobic gram-positive cocci), while chronic infections tend to be polymicrobial 2, 3
Aerobic gram-positive cocci, especially Staphylococcus aureus and beta-hemolytic streptococci, are the predominant pathogens in early or previously untreated infections 1, 2
Chronic wounds develop a more complex bacterial flora, including enterococci, Enterobacteriaceae, obligate anaerobes, Pseudomonas aeruginosa, and other gram-negative rods 2, 3

Foot ischemia increases the risk of wound infection and adversely affects infection outcomes 4, 5
The ankle-brachial index (ABI) may be falsely elevated in diabetic patients due to arterial calcification, making it an unreliable measure of ischemia in this population 6
Atherosclerosis in diabetic patients often involves the pedal arteries, contributing to poor wound healing and increased infection risk 4

Diabetic neuropathy plays a central role in foot ulceration, with disturbances affecting sensory, motor, and autonomic functions 2, 4
Neuropathy is not limited to sensory nerves but involves all three components:
- Sensory: loss of protective sensation leading to undetected trauma 7
- Motor: causing foot deformities and abnormal pressure points 7
- Autonomic: resulting in dry, cracking skin due to deficient sweating 7, 4

Diabetic foot infection is diagnosed clinically based on the presence of at least two classic signs of inflammation (redness, warmth, pain/tenderness, induration) or purulent secretions 1, 8
Infections are classified as mild (superficial), moderate (deeper or more extensive), or severe (with systemic signs) 1, 8
Wound cultures should be obtained from properly debrided tissue specimens rather than surface swabs to accurately identify causative organisms 1

Empiric antibiotic therapy should cover the most likely pathogens based on infection severity and chronicity 1, 2
Mild infections can often be treated with narrower-spectrum antibiotics targeting gram-positive cocci 1
Moderate to severe infections typically require broader coverage for gram-positive, gram-negative, and anaerobic organisms 1, 2
Surgical debridement is often necessary, especially in moderate to severe infections 1
Addressing vascular insufficiency is critical for successful treatment outcomes 1, 4

The presence of methicillin-resistant Staphylococcus aureus (MRSA) is associated with worse outcomes 2